E.g., 09/27/2022
E.g., 09/27/2022

bioMérieux – 2020 Financial Results

24 February, 2021

First-Half 2020 Results

02 September, 2020

bioMérieux serology tests for SARS-CoV-2 on VIDAS® undergo validation preceding imminent launch 

06 May, 2020

bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis

24 February, 2017

bioMérieux introduces EviSight™ Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production

06 October, 2016

bioMérieux acquires Hyglos

01 June, 2016

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products

bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals

11 April, 2016

Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed

FilmArray® Torch is now FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked

08 April, 2016

BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel  FilmArray® Torch delivers high throughput, radically smaller footprint

bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories

22 March, 2016

bioMérieux – 2015 Financial Results

02 March, 2016

Pioneering diagnostics